+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID07875582

Evaluating Blood Protein Biomarkers to Differentiate Pancreatic Cancer from Other Pancreatic Conditions in Adults

Led by Grigore T. Popa University of Medicine and Pharmacy · Updated on 2026-10-19

100

Participants Needed

1

Research Sites

8 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the diagnostic accuracy of blood-based protein biomarkers to detect pancreatic ductal adenocarcinoma PDAC in adults aged 18 and older. This multicenter observational study aims to determine whether these biomarkers can distinguish pancreatic cancer from chronic pancreatitis and mucinous pancreatic lesions, including intraductal papillary mucinous neoplasms IPMNs and mucinous cystic neoplasms MCNs. It also investigates if combining these biomarkers with CA 19-9 improves diagnostic accuracy and explores associations between biomarker levels and tumor characteristics. Participants will provide a blood sample before any oncological or interventional treatment to measure protein biomarkers such as GDF-15, ICAM-1, osteopontin, CXCL10, HGF, Nectin-4, periostin, and VEGF-A. Blood samples and clinical data will be collected from four groups those with PDAC, chronic pancreatitis, IPMNs, and MCNs. The biomarker measurements will be performed centrally using a validated multiplex assay. Routine laboratory tests and CA 19-9 levels will also be assessed. Participants will provide informed consent and supply an additional blood sample alongside routine tests. Relevant clinical, imaging, and laboratory information will be gathered to support analysis. Researchers will compare biomarker levels across diagnostic groups and assess diagnostic performance using statistical methods, including ROC curve analysis. No experimental treatments will be given, and all clinical care decisions remain routine. The study duration extends until late 2027.

CONDITIONS

Brief Title

Diagnostic Utility of Protein Biomarkers in Pancreatic Ductal Adenocarcinoma

Research Team

R

Roxana Grigorovici, medical doctor, PhD student

C

Catalin V Sfarti, medical doctor, professor

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here